Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Bagsværd, Denmark, 10 June – Novo Nordisk today announced that new data from its industry-leading portfolio in metabolic and cardiovascular health will be showcased at the upcoming American Diabete
Novo Nordisk shares rise 3% after reported activist stake-building
04:25am, Tuesday, 10'th Jun 2025
Shares in Novo Nordisk (NYSE:NVO), maker of fat-busting jabs such as Ozempic, jumped 3% after the emergence of an activist investor on its share register. Parvus Asset Management is building a stake i
2 Weight Loss Drug Stocks That Are Screaming Buys in June
03:33am, Tuesday, 10'th Jun 2025
Is there a hotter trend in healthcare than weight loss drugs? Probably not.
Why Novo Nordisk Stock Eked Out a Win on Monday
06:49pm, Monday, 09'th Jun 2025
Wegovy and Ozempic maker Novo Nordisk (NVO 1.11%) saw its stock price tick up slightly on Monday, on a media report about the possible entry of an activist investor. Market players cautiously bid the
Final Trade: NVO, CELH, LION, GILD
06:23pm, Monday, 09'th Jun 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports
01:33pm, Monday, 09'th Jun 2025
Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk , after the company lost its first mover advantage in the lucrative weight-loss drug market, the Financial Times reporte
With Novo Nordisk's CEO Out, Wall Street Wants an American Leader
08:44am, Saturday, 07'th Jun 2025
Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk A/S NYSE: NVO, Lars Fruergaard Jørgensen is on the outs. On May 16, Novo made the announcement that J�
June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
07:00am, Saturday, 07'th Jun 2025
Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term ear
Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?
01:40pm, Friday, 06'th Jun 2025
NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:06am, Friday, 06'th Jun 2025
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
Novo Nordisk Stock: Is It Still a Smart Buy?
04:40am, Friday, 06'th Jun 2025
Much like the long-term users of its most popular product, Novo Nordisk's (NVO 0.69%) stock has slimmed down considerably of late. Share prices of the company, which developed and sells weight loss dr
Why Novo Nordisk (NVO) is a Top Dividend Stock for Your Portfolio
12:46pm, Monday, 02'nd Jun 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes?
2 Top Stocks to Buy With Less Than $100
08:00am, Friday, 30'th May 2025
When investing on a budget, buying fractional shares of top companies is one option. Another is to find stocks with relatively affordable price tags per share.
2 Beaten-Down Stocks to Buy on the Dip
07:00am, Friday, 30'th May 2025
It won't come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this year. Some have encountered company-specific problems, others have been swept up in the marke
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
10:27am, Thursday, 29'th May 2025
Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.
